Endpoints News Names Eric Dube a 2024 LGBTQ+ Leader in BioPharma

Tuesday, June 25, 2024Today Eric Dube, Ph.D., president and CEO of Travere, was named an LGBTQ+ Leader in Biopharma by Endpoints News. In an interview with Endpoints, Eric reflects on the legacy of activists during the AIDS and HIV epidemic, and the impact of their work on patient advocacy and drug development today. He also talks about health equity, access to care, and the importance of listening to what patients need. Read the full article.